Paul M. Silva, SVP & Chief Accounting Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 2,898 shares at $214.32 ($622K) on 2021-02-25, disclosed to the SEC on 2021-02-26.
Seasonal sale ($622k) by SVP & Chief Accounting Officer — this insider has traded VRTX in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $217.57 | 864 | $188K | 30.2% |
| 2 | $211.80 | 244 | $52K | 8.3% |
| 3 | $211.80 | 244 | $52K | 8.3% |
| 4 | $213.12 | 452 | $96K | 15.5% |
| 5 | $213.12 | 452 | $96K | 15.5% |
| 6 | $214.32 | 258 |
| $55K |
| 8.9% |
| 7 | $214.32 | 258 | $55K | 8.9% |
| 8 | $216.25 | 126 | $27K | 4.4% |
| Total | $214.57 avg | 2,898 | $622K | 100% |
| Filing → |
| VRTX | SELL | 2021-02-16 | $586K | — | Filing → |
| VRTX | SELL | 2020-08-10 | $564K | — | Filing → |
| VRTX | SELL | 2020-08-05 | $431K | — | Filing → |